Saturday, 31 October 2026European Markets

ASM INTERNATIONAL And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Loading stream...

(VIANEWS) - ASM INTERNATIONAL (ASM.AS), KONGSBERG GRUPPEN (KOG.OL), WDP (WDP.BR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. ASM INTERNATIONAL (ASM.AS)

17.4% sales growth and 16.73% return on equity

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in Europe, the United States, and Asia. The company's products include wafer processing deposition systems for atomic layer deposition (ALD), epitaxy, silicon carbide, plasma enhanced chemical vapor deposition (PECVD), and vertical furnace systems, including low pressure chemical vapor deposition (LPCVD), diffusion, and oxidation products, as well as provides spare parts and support services. It also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €10.98.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 58.94. Meaning, the purchaser of the share is investing €58.94 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.73%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 3.1% and 23.8%, respectively.

Yearly Top and Bottom Value

ASM INTERNATIONAL's stock is valued at €647.20 at 22:20 EST, under its 52-week high of €658.60 and way higher than its 52-week low of €348.35.

More news about ASM INTERNATIONAL.

2. KONGSBERG GRUPPEN (KOG.OL)

14.7% sales growth and 25.08% return on equity

Kongsberg Gruppen ASA, together with its subsidiaries, provides high-tech systems and solutions primarily to customers in the maritime and defense markets. The company operates through three segments: Kongsberg Maritime, Kongsberg Defence & Aerospace, and Other. The Kongsberg Maritime segment offers solutions and systems for bridge and control systems, which include dynamic positioning, propulsion control, and navigation, as well as automation systems; energy solutions and ship design services; and propellers, thrusters, water jet systems, and systems for offshore manoeuvring of maritime vessels. This segment also provides winches for mooring, anchor handling, and special systems for offshore vessels, tugs, marine vessels, and various other classes of vessel, as well as cranes; hydroacoustics; autonomous underwater vessels and solutions for autonomous maritime vessels; and products related to fisheries, systems for underwater mapping, and sensors and solutions for specialist vessels. The Kongsberg Defence & Aerospace segment offers various systems and services to the defense industry. It provides air defense and combat systems, sonars, and navigation for marine vessels and submarines, as well as integrated command and control systems; remote tower solutions for airports; remote control weapon stations for land-based vehicles and marine vessels; products for military tactical communication; naval strike and air-to-surface missiles; and lightweight composite and titanium components for F-35 combat aircraft. This segment also offers components and services to the space industry, as well as port monitoring systems; and maintenance, repair, and overhaul services. The Other segment focuses on digitalization within the oil and gas, wind, and merchant marine markets. It operates primarily in Norway, Europe, North America, South America, Asia, Australia, and South Africa. Kongsberg Gruppen ASA was founded in 1814 and is headquartered in Kongsberg, Norway.

Earnings Per Share

As for profitability, KONGSBERG GRUPPEN has a trailing twelve months EPS of kr23.23.

PE Ratio

KONGSBERG GRUPPEN has a trailing twelve months price to earnings ratio of 37.17. Meaning, the purchaser of the share is investing kr37.17 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.08%.

Yearly Top and Bottom Value

KONGSBERG GRUPPEN's stock is valued at kr863.50 at 22:20 EST, higher than its 52-week high of kr839.00.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 22.8% and 22.3%, respectively.

More news about KONGSBERG GRUPPEN.

3. WDP (WDP.BR)

12.5% sales growth and 3.99% return on equity

WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.

Earnings Per Share

As for profitability, WDP has a trailing twelve months EPS of €0.11.

PE Ratio

WDP has a trailing twelve months price to earnings ratio of 249.27. Meaning, the purchaser of the share is investing €249.27 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.99%.

Sales Growth

WDP's sales growth is 14.5% for the present quarter and 12.5% for the next.

Volume

Today's last reported volume for WDP is 21939 which is 91.03% below its average volume of 244665.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 25, 2024, the estimated forward annual dividend rate is 1.12 and the estimated forward annual dividend yield is 4.07%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 20%, now sitting on 420.34M for the twelve trailing months.

More news about WDP.

4. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 19.84% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 17.32. Meaning, the purchaser of the share is investing kr17.32 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.84%.

Yearly Top and Bottom Value

VISTIN PHARMA's stock is valued at kr22.00 at 22:20 EST, way under its 52-week high of kr25.10 and above its 52-week low of kr20.60.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 5, 2024, the estimated forward annual dividend rate is 1.25 and the estimated forward annual dividend yield is 5.36%.

More news about VISTIN PHARMA.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com